{"id":"https://openalex.org/W2127680641","doi":"https://doi.org/10.1158/1078-0432.ccr-05-2255","title":"Phase II Clinical Trial Results Involving Treatment with Low-Dose Daily Oral Cyclophosphamide, Weekly Vinblastine, and Rofecoxib in Patients with Advanced Solid Tumors","display_name":"Phase II Clinical Trial Results Involving Treatment with Low-Dose Daily Oral Cyclophosphamide, Weekly Vinblastine, and Rofecoxib in Patients with Advanced Solid Tumors","publication_year":2006,"publication_date":"2006-05-15","ids":{"openalex":"https://openalex.org/W2127680641","doi":"https://doi.org/10.1158/1078-0432.ccr-05-2255","mag":"2127680641","pmid":"https://pubmed.ncbi.nlm.nih.gov/16707607"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.ccr-05-2255","doi":"https://doi.org/10.1158/1078-0432.ccr-05-2255","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-05-2255","pdf_url":"https://aacrjournals.org/clincancerres/article-pdf/12/10/3092/1921235/3092.pdf","source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://aacrjournals.org/clincancerres/article-pdf/12/10/3092/1921235/3092.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103947630","display_name":"Scott D. Young","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210164903","display_name":"Sudbury Regional Hospital","ror":"https://ror.org/05fkxeh29","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2802851750","https://openalex.org/I4210164903"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Scott D. Young","raw_affiliation_strings":["Authors' Affiliation: Systemic Treatment Program, Regional Cancer Program of the Ho\u0302pital Re\u0301gional de Sudbury Regional Hospital, Sudbury, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliation: Systemic Treatment Program, Regional Cancer Program of the Ho\u0302pital Re\u0301gional de Sudbury Regional Hospital, Sudbury, Ontario, Canada","institution_ids":["https://openalex.org/I4210164903"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060105041","display_name":"Mark Whissell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210164903","display_name":"Sudbury Regional Hospital","ror":"https://ror.org/05fkxeh29","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2802851750","https://openalex.org/I4210164903"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Mark Whissell","raw_affiliation_strings":["Authors' Affiliation: Systemic Treatment Program, Regional Cancer Program of the Ho\u0302pital Re\u0301gional de Sudbury Regional Hospital, Sudbury, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliation: Systemic Treatment Program, Regional Cancer Program of the Ho\u0302pital Re\u0301gional de Sudbury Regional Hospital, Sudbury, Ontario, Canada","institution_ids":["https://openalex.org/I4210164903"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109830744","display_name":"Jonathan Noble","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210164903","display_name":"Sudbury Regional Hospital","ror":"https://ror.org/05fkxeh29","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2802851750","https://openalex.org/I4210164903"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Jonathan C.S. Noble","raw_affiliation_strings":["Authors' Affiliation: Systemic Treatment Program, Regional Cancer Program of the Ho\u0302pital Re\u0301gional de Sudbury Regional Hospital, Sudbury, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliation: Systemic Treatment Program, Regional Cancer Program of the Ho\u0302pital Re\u0301gional de Sudbury Regional Hospital, Sudbury, Ontario, Canada","institution_ids":["https://openalex.org/I4210164903"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048034601","display_name":"Pablo Cano","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210164903","display_name":"Sudbury Regional Hospital","ror":"https://ror.org/05fkxeh29","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2802851750","https://openalex.org/I4210164903"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Pablo O. Cano","raw_affiliation_strings":["Authors' Affiliation: Systemic Treatment Program, Regional Cancer Program of the Ho\u0302pital Re\u0301gional de Sudbury Regional Hospital, Sudbury, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliation: Systemic Treatment Program, Regional Cancer Program of the Ho\u0302pital Re\u0301gional de Sudbury Regional Hospital, Sudbury, Ontario, Canada","institution_ids":["https://openalex.org/I4210164903"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103857395","display_name":"Pedro G. Lopez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210164903","display_name":"Sudbury Regional Hospital","ror":"https://ror.org/05fkxeh29","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2802851750","https://openalex.org/I4210164903"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Pedro G. Lopez","raw_affiliation_strings":["Authors' Affiliation: Systemic Treatment Program, Regional Cancer Program of the Ho\u0302pital Re\u0301gional de Sudbury Regional Hospital, Sudbury, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliation: Systemic Treatment Program, Regional Cancer Program of the Ho\u0302pital Re\u0301gional de Sudbury Regional Hospital, Sudbury, Ontario, Canada","institution_ids":["https://openalex.org/I4210164903"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5076680110","display_name":"Colin J. Germond","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210164903","display_name":"Sudbury Regional Hospital","ror":"https://ror.org/05fkxeh29","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2802851750","https://openalex.org/I4210164903"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Colin J. Germond","raw_affiliation_strings":["Authors' Affiliation: Systemic Treatment Program, Regional Cancer Program of the Ho\u0302pital Re\u0301gional de Sudbury Regional Hospital, Sudbury, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliation: Systemic Treatment Program, Regional Cancer Program of the Ho\u0302pital Re\u0301gional de Sudbury Regional Hospital, Sudbury, Ontario, Canada","institution_ids":["https://openalex.org/I4210164903"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210164903"],"apc_list":null,"apc_paid":null,"fwci":2.5825,"has_fulltext":true,"cited_by_count":110,"citation_normalized_percentile":{"value":0.89948794,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":99},"biblio":{"volume":"12","issue":"10","first_page":"3092","last_page":"3098"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.6226000189781189,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.6226000189781189,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.08070000261068344,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.07769999653100967,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metronomic-chemotherapy","display_name":"metronomic chemotherapy","score":0.9700000286102295},{"id":"https://openalex.org/keywords/low-dose-cyclophosphamide","display_name":"low-dose cyclophosphamide","score":0.9340000152587891},{"id":"https://openalex.org/keywords/vinblastine","display_name":"vinblastine","score":0.9729999899864197},{"id":"https://openalex.org/keywords/rofecoxib","display_name":"rofecoxib","score":1.0},{"id":"https://openalex.org/keywords/advanced-solid-tumors","display_name":"advanced solid tumors","score":0.9290000200271606},{"id":"https://openalex.org/keywords/anti-angiogenic-therapy","display_name":"anti-angiogenic therapy","score":0.7940000295639038},{"id":"https://openalex.org/keywords/minocycline","display_name":"minocycline","score":0.9449999928474426},{"id":"https://openalex.org/keywords/tumor-angiogenesis","display_name":"tumor angiogenesis","score":0.703000009059906},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.6940000057220459},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8870000243186951},{"id":"https://openalex.org/keywords/chemotherapy-toxicity","display_name":"chemotherapy toxicity","score":0.734000027179718},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.781000018119812}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8970606327056885},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6134315133094788},{"id":"https://openalex.org/C2778496288","wikidata":"https://www.wikidata.org/wiki/Q6931269","display_name":"Mucositis","level":3,"score":0.5921456813812256},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.5435424447059631},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.5258995890617371},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.49259239435195923},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.475197434425354},{"id":"https://openalex.org/C2777132456","wikidata":"https://www.wikidata.org/wiki/Q282629","display_name":"Vinblastine","level":3,"score":0.47302910685539246},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.4662092626094818},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.45830678939819336},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.43985849618911743},{"id":"https://openalex.org/C2776907518","wikidata":"https://www.wikidata.org/wiki/Q1734165","display_name":"Performance status","level":3,"score":0.4243125319480896},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4158020317554474},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.40880680084228516}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007783","descriptor_name":"Lactones","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D013450","descriptor_name":"Sulfones","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014747","descriptor_name":"Vinblastine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.ccr-05-2255","doi":"https://doi.org/10.1158/1078-0432.ccr-05-2255","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-05-2255","pdf_url":"https://aacrjournals.org/clincancerres/article-pdf/12/10/3092/1921235/3092.pdf","source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},{"id":"pmid:16707607","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16707607","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Clinical Trial, Phase II"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.ccr-05-2255","doi":"https://doi.org/10.1158/1078-0432.ccr-05-2255","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-05-2255","pdf_url":"https://aacrjournals.org/clincancerres/article-pdf/12/10/3092/1921235/3092.pdf","source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2127680641.pdf","grobid_xml":"https://content.openalex.org/works/W2127680641.grobid-xml"},"referenced_works_count":49,"referenced_works":["https://openalex.org/W35799166","https://openalex.org/W103592546","https://openalex.org/W142377240","https://openalex.org/W1561881745","https://openalex.org/W1573738975","https://openalex.org/W1595263809","https://openalex.org/W1708269992","https://openalex.org/W1927808513","https://openalex.org/W1929987490","https://openalex.org/W1943173994","https://openalex.org/W1969702239","https://openalex.org/W1975601342","https://openalex.org/W1975829266","https://openalex.org/W1977535902","https://openalex.org/W1983674005","https://openalex.org/W1989028508","https://openalex.org/W1992195528","https://openalex.org/W1998473149","https://openalex.org/W1998855245","https://openalex.org/W2018317269","https://openalex.org/W2019265097","https://openalex.org/W2022662750","https://openalex.org/W2028665955","https://openalex.org/W2029883816","https://openalex.org/W2032554444","https://openalex.org/W2043410848","https://openalex.org/W2053048852","https://openalex.org/W2054429544","https://openalex.org/W2064329945","https://openalex.org/W2102392974","https://openalex.org/W2104316189","https://openalex.org/W2106213387","https://openalex.org/W2107139417","https://openalex.org/W2110224954","https://openalex.org/W2117011972","https://openalex.org/W2124951418","https://openalex.org/W2129497878","https://openalex.org/W2140868957","https://openalex.org/W2144874683","https://openalex.org/W2156994528","https://openalex.org/W2162149445","https://openalex.org/W2169965478","https://openalex.org/W2169992085","https://openalex.org/W2230845873","https://openalex.org/W2234354671","https://openalex.org/W2409681599","https://openalex.org/W2412575467","https://openalex.org/W2536704472","https://openalex.org/W2604797422"],"related_works":["https://openalex.org/W2588309151","https://openalex.org/W2247833902","https://openalex.org/W4246345261","https://openalex.org/W2272627972","https://openalex.org/W7100107471","https://openalex.org/W2217934135","https://openalex.org/W2218471737","https://openalex.org/W1912629638","https://openalex.org/W2154736427","https://openalex.org/W2120304148"],"abstract_inverted_index":{"PURPOSE:":[0],"Preclinical":[1],"studies":[2],"indicate":[3,316],"that":[4,317],"conventional":[5],"chemotherapeutic":[6],"agents":[7],"given":[8,283,308],"continuously":[9],"at":[10,37,64,93,164],"low":[11],"doses":[12],"(metronomic":[13],"chemotherapy)":[14],"may":[15],"provide":[16],"an":[17,156,186],"improved":[18],"therapeutic":[19],"index.":[20],"Cyclophosphamide":[21],"and":[22,92,105,180,232,255,279,292,315],"vinblastine":[23,116,281],"have":[24,74],"been":[25],"best":[26],"studied":[27],"in":[28,39,54,110,323],"experimental":[29],"models,":[30],"where":[31],"tumor":[32,137],"growth":[33],"inhibition":[34],"is":[35,287],"achieved,":[36],"least":[38,65,94,165],"part,":[40],"through":[41],"antiangiogenic":[42],"mechanisms.":[43],"EXPERIMENTAL":[44],"DESIGN:":[45],"Fifty":[46],"patients":[47,99,122,154,196,228,236,243,259,298],"with":[48,131,285,289,299],"advanced":[49,300],"solid":[50,301],"tumors":[51],"were":[52,71,175,248],"enrolled":[53],"this":[55,318],"phase":[56],"II":[57],"trial,":[58],"43":[59],"of":[60,81,89,115,120,134,143,153,191,212,242,275,311],"whom":[61],"had":[62],"received":[63,100,124],"one":[66,95],"prior":[67],"chemotherapy":[68],"regimen.":[69],"Patients":[70],"required":[72],"to":[73,112,297],"Eastern":[75],"Cooperative":[76],"Oncology":[77],"Group":[78],"performance":[79],"status":[80],"<":[82],"or":[83,159,203,263,268],"=":[84,204],"2,":[85],"a":[86],"life":[87],"expectancy":[88],">3":[90],"months,":[91],"measurable":[96],"lesion.":[97],"All":[98],"oral":[101,277],"cyclophosphamide":[102,278],"(50":[103],"mg)":[104,108,127],"rofecoxib":[106,286],"(25":[107],"daily":[109,130,276],"addition":[111],"weekly":[113,280],"injections":[114,282],"(3":[117],"mg/m2).":[118],"Half":[119],"the":[121,132,144,151,170,309,312],"also":[123],"minocycline":[125],"(100":[126],"orally":[128],"twice":[129],"intent":[133],"further":[135,321],"inhibiting":[136],"angiogenesis.":[138],"The":[139,208,222,240],"primary":[140,209],"end":[141,210],"point":[142,211],"study":[145,313],"was":[146,215,229],"clinical":[147,213,238,295],"benefit,":[148],"defined":[149],"as":[150,249],"percentage":[152],"experiencing":[155,237,244],"objective":[157,188],"response":[158,189],"exhibiting":[160],"stable":[161],"disease":[162,198,201,325],"for":[163,185,226,235],"6":[166,205],"months.":[167],"RESULTS:":[168],"For":[169],"47":[171],"eligible":[172],"patients,":[173],"there":[174],"two":[176],"(4%)":[177],"complete":[178],"responses":[179],"four":[181],"(9%)":[182],"partial":[183],"responses,":[184],"overall":[187],"rate":[190],"13%.":[192],"An":[193],"additional":[194],"eight":[195],"achieved":[197],"stabilization":[199],"(stable":[200],">":[202],"months)":[206],"(17%).":[207],"benefit":[214,296],"therefore":[216],"30%,":[217],"(95%":[218],"confidence":[219],"interval,":[220],"16-44%).":[221],"median":[223],"progression-free":[224],"survival":[225],"all":[227],"103":[230],"days":[231,234],"289":[233],"benefit.":[239],"incidence":[241],"grade":[245,261],"3/4":[246],"toxicities":[247],"follows:":[250],"neutropenia":[251],"(10/2),":[252],"anemia":[253],"(2/0),":[254],"thrombocytopenia":[256],"(1/0).":[257],"No":[258],"developed":[260],"3":[262],"4":[264],"nausea,":[265],"vomiting,":[266],"mucositis,":[267],"alopecia.":[269],"CONCLUSIONS:":[270],"This":[271],"low-dose":[272],"regimen":[273],"consisting":[274],"concurrently":[284],"associated":[288],"minimal":[290],"toxicity":[291],"provides":[293],"significant":[294],"tumors.":[302],"These":[303],"results":[304],"are":[305],"particularly":[306],"encouraging":[307],"nature":[310],"population":[314],"approach":[319],"merits":[320],"investigation":[322],"specific":[324],"site":[326],"studies.":[327]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":9},{"year":2014,"cited_by_count":9},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":13}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}